BR0101611A - Processo para a preparação do sal mesilato tri-hidrato de 1-(4-hidroxifenil)-2-(4-hidróxi-4-fenilpiperidin-1-il)-1-propanol e in-termediários úteis para esse processo - Google Patents

Processo para a preparação do sal mesilato tri-hidrato de 1-(4-hidroxifenil)-2-(4-hidróxi-4-fenilpiperidin-1-il)-1-propanol e in-termediários úteis para esse processo

Info

Publication number
BR0101611A
BR0101611A BR0101611-3A BR0101611A BR0101611A BR 0101611 A BR0101611 A BR 0101611A BR 0101611 A BR0101611 A BR 0101611A BR 0101611 A BR0101611 A BR 0101611A
Authority
BR
Brazil
Prior art keywords
phenylpiperidin
hydroxyphenyl
propanol
hydroxy
preparation
Prior art date
Application number
BR0101611-3A
Other languages
English (en)
Inventor
Joseph Philip Rainville
Terry Gene Sinay Jr
Stanley Walter Walinsky
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0101611A publication Critical patent/BR0101611A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Patente de Invenção: "PROCESSO PARA A PREPARAçãO DO SAL MESILATO TRI-HIDRATO DE 1-(4-HIDROXIFENIL)-2-(4-HIDRóXI-4-FENILPIPERIDIN-1-IL)-1-PROPANOL E INTERMEDIáRIOS úTEIS PARA ESSE PROCESSO". A presente invenção refere-se a um novo processo para a preparação de um tri-hidrato do mesilato do composto de fórmula (I), (1S,2S)-1-(4-hidroxifenil)-2-(4-hidróxi-4-fenilpiperidin-1-il)-1-propanol: A presente invenção também refere-se ao processo de preparação do composto-(2S)-(+) de fórmula (II): em que R1 é um grupo protetor: Para além disso, a presente invenção refere-se a intermediários úteis nos referidos processos.
BR0101611-3A 2000-04-28 2001-04-26 Processo para a preparação do sal mesilato tri-hidrato de 1-(4-hidroxifenil)-2-(4-hidróxi-4-fenilpiperidin-1-il)-1-propanol e in-termediários úteis para esse processo BR0101611A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20041700P 2000-04-28 2000-04-28

Publications (1)

Publication Number Publication Date
BR0101611A true BR0101611A (pt) 2002-01-15

Family

ID=22741639

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0101611-3A BR0101611A (pt) 2000-04-28 2001-04-26 Processo para a preparação do sal mesilato tri-hidrato de 1-(4-hidroxifenil)-2-(4-hidróxi-4-fenilpiperidin-1-il)-1-propanol e in-termediários úteis para esse processo

Country Status (26)

Country Link
US (1) US6570018B2 (pt)
EP (1) EP1149831B1 (pt)
JP (1) JP2001354650A (pt)
KR (1) KR100432841B1 (pt)
CN (1) CN1211366C (pt)
AR (1) AR028377A1 (pt)
AT (1) ATE275130T1 (pt)
AU (1) AU781715B2 (pt)
BR (1) BR0101611A (pt)
CA (1) CA2345286C (pt)
CZ (1) CZ20011472A3 (pt)
DE (1) DE60105221T2 (pt)
DK (1) DK1149831T3 (pt)
ES (1) ES2225425T3 (pt)
HK (1) HK1040514B (pt)
HU (1) HUP0101725A3 (pt)
ID (1) ID30012A (pt)
IL (1) IL142706A0 (pt)
IN (1) IN191534B (pt)
PL (1) PL347299A1 (pt)
PT (1) PT1149831E (pt)
RU (1) RU2192415C1 (pt)
SI (1) SI1149831T1 (pt)
TW (1) TWI222440B (pt)
YU (1) YU27801A (pt)
ZA (1) ZA200103321B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743921B2 (en) * 2002-01-24 2004-06-01 Dsm Catalytica Pharmaceuticals, Inc. Process for the preparation of nonracemic syn-1-(4-hydroxy-phenyl)-2-(4-hydroxy-4-phenyl-piperidin-1-yl)-1-propanol compounds
CN105037221B (zh) * 2015-06-18 2017-05-10 吉林大学珠海学院 一种具有神经保护作用的化合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR199800208T1 (pt) 1995-08-11 1998-05-21 Pfizer Inc.
TW450807B (en) * 1995-09-15 2001-08-21 Pfizer Pharmaceutical compositions for treating tinnitus comprising neuroprotective agents

Also Published As

Publication number Publication date
SI1149831T1 (en) 2005-02-28
ES2225425T3 (es) 2005-03-16
DK1149831T3 (da) 2004-12-06
TWI222440B (en) 2004-10-21
AU781715B2 (en) 2005-06-09
RU2192415C1 (ru) 2002-11-10
CZ20011472A3 (cs) 2001-12-12
ID30012A (id) 2001-11-01
EP1149831B1 (en) 2004-09-01
IN191534B (pt) 2003-12-06
HUP0101725A2 (hu) 2002-02-28
DE60105221D1 (de) 2004-10-07
DE60105221T2 (de) 2005-09-15
PL347299A1 (en) 2001-11-05
EP1149831A1 (en) 2001-10-31
AR028377A1 (es) 2003-05-07
US20020016466A1 (en) 2002-02-07
CN1322716A (zh) 2001-11-21
JP2001354650A (ja) 2001-12-25
KR100432841B1 (ko) 2004-05-24
CN1211366C (zh) 2005-07-20
AU3889701A (en) 2001-12-13
ZA200103321B (en) 2002-10-24
HUP0101725A3 (en) 2003-04-28
HK1040514B (zh) 2005-10-28
KR20010098924A (ko) 2001-11-08
CA2345286A1 (en) 2001-10-28
PT1149831E (pt) 2004-11-30
IL142706A0 (en) 2002-03-10
HU0101725D0 (en) 2001-07-30
US6570018B2 (en) 2003-05-27
ATE275130T1 (de) 2004-09-15
HK1040514A1 (en) 2002-06-14
CA2345286C (en) 2004-11-09
YU27801A (sh) 2003-04-30

Similar Documents

Publication Publication Date Title
BR0013876A (pt) Derivado de triazinil aminostilbeno como agentes de branqueamento fluorescente
BR9909844A (pt) Processo para sintetizar um composto, e, composto.
BR0213233A (pt) Alcinos inibidores de metaloproteinase de matriz
CO4910126A1 (es) 2-cianopirrolidinas n sustituidas
BR0307236A (pt) Processo para fabricação de compostos orgânicos
BR9810657A (pt) "processo de preparação de um per-hidroisoindol substituìdo"
BR0101230A (pt) Processo para a preparação de11-amino-3-cloro-6,11-diidro-5-5-dioxo-6-metil-dibenzo[c,f][1,2]tiazepina e aplicação para a sìntese detianeptina
BR9813036A (pt) Processo para fazer compostos quirais
BRPI0409471B8 (pt) processo para preparação de 2-cianopirrolidinas n-substituídas
BR0215258A (pt) Moduladores de receptor x de fìgado de tioéter aromático
BR0215067A (pt) Piridoquinoxalinas antivirais
BR9808854A (pt) Processo para preparação de um composto, e, composto
BR0101611A (pt) Processo para a preparação do sal mesilato tri-hidrato de 1-(4-hidroxifenil)-2-(4-hidróxi-4-fenilpiperidin-1-il)-1-propanol e in-termediários úteis para esse processo
BR9914438A (pt) Processo aperfeiçoado para a preparação de novos agentes anti-diabéticos
BR9911250A (pt) Processo para preparação de compostos
BR0113259A (pt) Processo para a preparação de um composto, composto e processo para a preparação de compostos
BR9711189A (pt) Processo para a prepara-Æo de n-¬(1 butil-4-piperdil) metil¾-3,4-diidro-2h-¬1,3-oc¾indol-10-carboxamida e sais e intermediarios no processo (57) "processo para a prepara-Æo de n-¬(1-nbutil-4-piperdil) metil¾-3,4-diiro-2h--1-3-¾indol-1 0-carboxamida e sais e intermedi rios no processo a presente inven-Æo refere-se prepara-Æo de sb207266 ou um seu sal farmaceuticamente aceit vel cujo processo compreende a rea-Æo de n-(1-nbutil-4-piperidilmetil amina com um composto de fÄrmula (a) em que r e alqu
BR9809809A (pt) Processo para a preparação de um composto, e, proxetina
BR0101630A (pt) Processo para a preparação do trihidrato do salmesilato de1-(4-hidroxifenil)-2(4-hidróxi-4fenilpiperidin-1-il)-1-propanol
BR9911794A (pt) Derivados anti-histamìnicos de piperidina e intermediários para a preparação dos mesmos
BR0205172A (pt) Processo para a sìntese de esfingosina
BR0206585A (pt) Processo para a preparação de intermediários para a fabricação de discodermolìdeo e análogos de discodermolìdeo
BR0116721A (pt) Processo para a preparação de (±)-trans-4-p-fluorofenil-3-hidroximetil-1-metilpiperi dina
BR9916382A (pt) Processo para a preparação de um composto
BR9906803A (pt) Processo para tratamento de copd

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7O E 8O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2012 DE 28/07/2009.